Episode Details
Back to Episodes
Eli Dorf (Bask Health) - What is Hims’ moat if anyone can launch a telehealth startup overnight?
Description
In episode 67 of Hims House, Jonathan Stern hosts Eli Dorf, founder and president of Bask Health. Bask provides the operating infrastructure for telehealth brands to launch quickly, choose pharmacy and clinical partners, route patients, process payments, and fulfill medications. Eli explains why outsourced infrastructure can let small teams scale fast, what Medvi’s rise reveals about the telehealth stack, and why he sees Hims’ strongest moat as brand trust and customer scale rather than pure technology. They also discuss pricing pressure in compounded GLP-1s, FDA enforcement, 503A compounding latitude, and why fragmentation could keep compressing margins. The conversation closes with peptides, LegitScript and payments hurdles, trusted brands, wearables, the health super app race, and whether Ro could go public.
00:00 - Sponsor: Superpower
02:18 - What Bask Health does
03:19 - Launching a telehealth brand overnight
07:21 - Can anyone copy Hims?
14:28 - Bask's business model
16:28 - Fragmentation hits telehealth margins
19:48 - Medvi’s cautionary tale
21:56 - What are Hims’ real moats
25:29 - Data, AI, and wearables
26:39 - Should Hims sell hardware?
30:15 - FDA pressure on GLP-1s
33:44 - Peptides as the next GLP-1 moment
36:48 - Payment processing and LegitScript
41:05 - Why peptide trust matters
43:52 - The health super-app race
47:44 - Ro vs Hims
50:45 - Will Ro go public?
Disclaimer: This podcast is for informational and entertainment purposes only. Nothing discussed should be considered financial, investment, or legal advice. Always consult with a qualified professional before making financial decisions.